BioHealth News Archive
ARPA-H announces small business funding opportunity
Agency seeks proposals for innovative research and development from small businesses The Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S.…
Read More
CraniUS™ Awarded Competitive $1 Million Grant from the State of Maryland’s Build Our Future Innovation Infrastructure Program
BALTIMORE--(BUSINESS WIRE)--CraniUS™, an R&D company focused on groundbreaking diagnostics and treatments for patients with chronic brain disease, has been awarded a competitive $1 million…
Read More
TEDCO Announces Second Year of Maryland Makerspace Initiative Program Awardees
18 projects will receive funding to support their growth and development COLUMBIA, Md., (June 27, 2024) — TEDCO, Maryland’s economic engine for technology companies,…
Read More
Fierce Healthcare: AWS doles out part of $10M grant to major children’s hospitals to advance pediatric cancer treatment
WASHINGTON, D.C. — Amazon Web Services committed $10 million to fund pediatric rare disease research, including cancer, on Wednesday at its annual summit in…
Read More
Maryland Daily Record: Germantown’s new incubator expected to spur regional biosciences growth
In Montgomery County, where incubator spaces are in high demand and existing facilities often have to turn away new entrepreneurs and startups, a new…
Read More
Welldoc Announces Collaboration to Support Cardiometabolic Health by Integrating AI-Driven Digital Coaching with Instacart’s Innovative Technology Platform to Increase Access to Nutritious Groceries
COLUMBIA, Md., June 25, 2024 — Welldoc®, a leading digital health company specializing in AI-driven cardiometabolic health, today announced a collaboration with Instacart, the leading…
Read More
REGENXBIO Announces Expansion of AFFINITY DUCHENNE® Trial to Include a New Cohort of Younger Patients
ROCKVILLE, Md., June 24, 2024 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it initiated enrollment in a new cohort of patients ages 1-3 in its Phase I/II…
Read More
Ascentage Pharma Announces Closing of US$75 Million Equity Investment by Takeda
ROCKVILLE, Md. and SUZHOU, China, June 20, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB),…
Read More
Emergent BioSolutions Announces Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals for $30 Million
GAITHERSBURG, Md., June 20, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has entered into a definitive agreement to sell its drug product…
Read More
RichmondBizSense: Life sciences startup support program looks to boost biohealth industry in Richmond
Ianne Salvosa June 18, 2024 - Efforts are afoot to make Richmond more of a player in the biohealth industry. Downtown-based Activation Capital is…
Read More
UMD Receives Entrepreneurial University Award at Annual Innovation Symposium
College Park, Md.—The University of Maryland was spotlighted for its innovative curriculum and robust student engagement in entrepreneurship at the annual Deshpande Symposium on Innovation…
Read More
BizJournals: A thriving quality of life in Montgomery County with TEDCO
By Tammi Thomas – Chief Development and Marketing Officer, TEDCO - Jun 17, 2024 Montgomery County, Maryland, is home to a thriving ecosystem of innovators and researchers…
Read More
Unlock Your Innovation Potential with BioHealth Innovation’s Grant Mapping Services
Navigating the complex landscape of non-dilutive funding can be daunting for many innovators and researchers. Identifying suitable grants that align with specific project goals…
Read More
Northwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual Property
BETHESDA, Md., June 17, 2024 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that…
Read More
Ascentage Pharma Signs Option Agreement with Takeda to Enter into Exclusive Global License for Olverembatinib, a Third-Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI)
ROCKVILLE, Md. and SUZHOU, China, June 14, 2024 /PRNewswire/ -- Ascentage Pharma (6855 HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B…
Read More